The 11 Biggest GLP-1 Myths, Busted by Expert Dietitians

If you’ve spent any time on social media lately, you might have seen conflicting claims about GLP-1 weight loss medications. One post says they’ll completely kill your appetite. Another warns about scary side effects. Someone else declares losing weight this way is “cheating.” With all the noise out there, it’s tough to know what’s actually […]

Inspire Medical (INSP) Fell Due to Multiple Headwinds

Mairs & Power, an investment advisor, released the third-quarter 2025 investor letter for the “Mairs & Power Small Cap Fund.” A copy of the letter can be downloaded here. The market’s concentration persists in 2025, with a few dominant mega-cap stocks tied to artificial intelligence (AI) driving most of the favorable outcomes. The fund returned […]

Here’s How GLP-1 Affected MGP Ingredients (MGPI) in Q3

Mairs & Power, an investment advisor, released the third-quarter 2025 investor letter for the “Mairs & Power Small Cap Fund.” A copy of the letter can be downloaded here. The market’s concentration persists in 2025, with a few dominant mega-cap stocks tied to artificial intelligence (AI) driving most of the favorable outcomes. The fund returned […]

STAT+: Wave’s ‘gym bro’ obesity drug is story over substance

This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox. I’m just back from the ASH meeting in Orlando, so a shorter-than-normal newsletter this week.  “Mean Adam” is also back. You’ll see below.  Continue to STAT+ to read the full story…

Life, Vol. 15, Pages 1893: The Role of Glucagon-like Peptide-1 Receptor Agonists in Alzheimer’s and Parkinson’s Disease: A Literature Review of Clinical Trials

Life, Vol. 15, Pages 1893: The Role of Glucagon-like Peptide-1 Receptor Agonists in Alzheimer’s and Parkinson’s Disease: A Literature Review of Clinical Trials Life doi: 10.3390/life15121893 Authors: Joanna Pilśniak Julia Węgrzynek-Gallina Błażej Bednarczyk Aleksandra Buczek Aleksandra Pilśniak Tomasz Chmiela Agnieszka Jarosińska Joanna Siuda Michał Holecki Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are widely used in the […]